• Gates Foundation Funds Studies Into CRISPR/Cas9 Gene Editing for SCD
  • Switching Treatments Helped to Reduce My Iron Overload
  • ARU-1801 Gene Therapy Granted Orphan Drug Status in EU
  • Why I Will Be Getting the COVID-19 Vaccine
  • Latest NORD Webinar Offers Insights on Starting Nonprofit, Patient Registry
  • Rifaximin, Oral Antibiotic, Named Orphan Drug for Potential to Ease Pain Crises
  • FT-4202, Oral SCD Therapy in Clinical Testing, Named Orphan Drug in EU
  • ‘Disabled’ Is Not a Bad Word
  • NIH Funds New Project to Improve SCD Care for Children in Malawi
  • What Does It Mean to Be Successful?
  • NORD Hosting ‘RareLaunch’ Workshops to Help Start Rare Disease Non-profits
  • CSL889 Designated as Orphan Drug in Europe and US for Treating Sickle Cell Disease